Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Italy.
Department of Precision Medicine, University of Campania Luigi Vanvitelli, Naples, Italy.
Clin Exp Rheumatol. 2022 Sep;40(8):1517-1525. doi: 10.55563/clinexprheumatol/0215kv. Epub 2022 May 4.
In this study, we aimed at describing the clinical characteristics, life-threatening complications occurrence, and mortality of adult-onset Still's disease (AOSD) patients with elderly onset.
A multicentre retrospective study of prospectively followed-up AOSD patients included in Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort was performed.
Out of 221 assessed patients, 37 (16.7%) had an onset of the disease aged over 60 years. When compared with younger patients, these were characterised by a higher prevalence of pericarditis (p=0.008), comorbidities (p<0.0001), and mortality (p=0.023). Age predicted the presence of serositis in both univariate (HR: 1.02, 95%CI: 1.01-1.03, p=0.007) and multivariate analyses (HR: 1.02, 95%CI: 1.01-1.04, p=0.007). Age was also a significant predictor of parenchymal lung disease in both univariate (HR: 1.03, 95%CI: 1.01-1.05, p=0.017) and multivariate analyses (HR: 1.03, 95%CI: 1.00-1.05, p=0.048). Furthermore, age resulted to be a negative predictor of polycyclic pattern only in univariate analysis (HR: 0.99, 95%CI: 0.97-1.00, p=0.048). Finally, age significantly predicted the mortality in both univariate (HR: 1.03, 95%CI: 1.00-1.06, p=0.034) and multivariate analyses (HR: 1.05, 95%CI: 1.01-1.08, p=0.012).
Clinical features of AOSD patients in the elderly were described in our cohort. Although the main clinical characteristics were similar comparing older and younger patients, patients aged over 60 years at disease onset were characterised by an increased prevalence of serositis, comorbidities, mostly cardiometabolic, and a higher mortality rate. Age predicted the presence of parenchymal lung disease and mortality, and it could be considered a negative prognostic factor in AOSD.
本研究旨在描述老年起病的成人Still 病(AOSD)患者的临床特征、发生危及生命的并发症和死亡率。
对纳入意大利临床和实验风湿病研究组(GIRRCS)队列的前瞻性随访的 AOSD 患者进行多中心回顾性研究。
在评估的 221 名患者中,37 名(16.7%)发病年龄超过 60 岁。与年轻患者相比,这些患者心包炎(p=0.008)、合并症(p<0.0001)和死亡率(p=0.023)更高。年龄在单变量(HR:1.02,95%CI:1.01-1.03,p=0.007)和多变量分析(HR:1.02,95%CI:1.01-1.04,p=0.007)中均为发生浆膜炎的预测因素。年龄也是单变量(HR:1.03,95%CI:1.01-1.05,p=0.017)和多变量分析(HR:1.03,95%CI:1.00-1.05,p=0.048)中预测实质性肺病的显著预测因素。此外,年龄仅在单变量分析中是多环模式的负预测因子(HR:0.99,95%CI:0.97-1.00,p=0.048)。最后,年龄在单变量(HR:1.03,95%CI:1.00-1.06,p=0.034)和多变量分析(HR:1.05,95%CI:1.01-1.08,p=0.012)中均显著预测死亡率。
我们的队列描述了老年起病的 AOSD 患者的临床特征。尽管比较年轻和老年患者的主要临床特征相似,但发病时年龄超过 60 岁的患者浆膜炎、合并症(主要是心血管代谢疾病)的发生率更高,死亡率更高。年龄预测实质性肺病和死亡率,可被视为 AOSD 的一个负预后因素。